Kidney cancer vaccine abandoned after failure of phase 3 clinical trial
Argos Therapeutics has abandoned its phase 3 trial of rocapuldencel-T (a [...]
Argos Therapeutics has abandoned its phase 3 trial of rocapuldencel-T (a [...]
An independent data monitoring committee (IDMC) has recommended that the phase 3 [...]